Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
19.45
-0.05 (-0.26%)
At close: Dec 20, 2024, 4:00 PM
19.32
-0.13 (-0.67%)
After-hours: Dec 20, 2024, 4:24 PM EST
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of $2.42 billion as of December 20, 2024. Its market cap has decreased by -5.30% in one year.
Market Cap
2.42B
Enterprise Value
2.59B
1-Year Change
-5.30%
Ranking
Category
Stock Price
$19.45
Market Cap Chart
Since June 30, 2004, Arrowhead Pharmaceuticals's market cap has increased from $95.40M to $2.42B, an increase of 2,436.95%. That is a compound annual growth rate of 17.10%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 19, 2024 | 2.43B | -26.19% |
Dec 29, 2023 | 3.29B | -23.54% |
Dec 30, 2022 | 4.30B | -37.84% |
Dec 31, 2021 | 6.92B | -11.95% |
Dec 31, 2020 | 7.86B | 29.67% |
Dec 31, 2019 | 6.06B | 451.13% |
Dec 31, 2018 | 1.10B | 299.42% |
Dec 29, 2017 | 275.20M | 154.58% |
Dec 30, 2016 | 108.10M | -70.48% |
Dec 31, 2015 | 366.20M | -9.27% |
Dec 31, 2014 | 403.60M | -3.88% |
Dec 31, 2013 | 419.90M | 1,153.43% |
Dec 31, 2012 | 33.50M | -24.04% |
Dec 30, 2011 | 44.10M | -31.42% |
Dec 31, 2010 | 64.30M | 93.09% |
Dec 31, 2009 | 33.30M | -15.70% |
Dec 31, 2008 | 39.50M | -72.93% |
Dec 31, 2007 | 145.90M | -2.60% |
Dec 29, 2006 | 149.80M | 25.99% |
Dec 30, 2005 | 118.90M | 101.87% |
Dec 31, 2004 | 58.90M | -38.26% |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
HUTCHMED (China) | 2.55B |
Kymera Therapeutics | 2.53B |
Concentra Group Holdings Parent | 2.49B |
Surgery Partners | 2.48B |
Dyne Therapeutics | 2.47B |
Privia Health Group | 2.42B |
Amneal Pharmaceuticals | 2.40B |
Protagonist Therapeutics | 2.36B |